General Health

Pirola: All You Need To Know About This New COVID Variant

6 min read

By Apollo 24|7, Published on- 06 September 2023

  • Share this article

  • 0

  • 0 like

As we were breathing a sigh of relief from the ongoing pandemic, a new COVID variant, Pirola, has caught the attention of scientists and researchers. It is crucial to understand the characteristics and implications of this variant to effectively combat its spread. In this article, we will provide you with all the essential information about this latest COVID variant, including its definition, transmission, symptoms, vaccination effectiveness, prevention measures and more.

What is the Pirola Variant?

The Pirola variant is a newly identified variant of the SARS-CoV-2 virus, which causes COVID-19. It has multiple genetic differences from previous versions of the virus, making it distinct.

1. Origin and Spread of the Pirola variant

The Pirola variant was initially detected in Denmark and Israel. However, it has now been found in several other countries, including the United States. This suggests international transmission of this new variant of COVID.

2. Genetic Mutations in the Pirola Variant

The Pirola variant carries specific genetic mutations that distinguish it from other variants. These mutations have the potential to impact how the virus behaves and interacts with our immune systems.

Transmission and Infectivity of Pirola

Here's what you need to know about the transmission and infectivity of this latest COVID variant:

  • Mode of Transmission: The Pirola variant spreads through respiratory droplets when an infected person coughs, sneezes, talks or breathes heavily. It can also be transmitted by touching surfaces contaminated with the virus and then touching your face.
  • Infectivity Rate and transmissibility: While more research is needed to determine the exact infectivity rate and transmissibility of the Pirola variant, early evidence suggests that it spreads in a similar manner as other variants of SARS-CoV-2. The fact that it has been identified across multiple continents does indicate a higher degree of transmissibility.

Symptoms and Severity of Pirola

Recognising the symptoms and understanding the severity of illness caused by the Pirola variant is crucial for early detection and appropriate medical intervention.

1. Common Symptoms

Individuals infected with the Pirola variant may experience symptoms similar to those seen in other COVID-19 variants. These can include:

  • Fever
  • Cough
  • Sore throat
  • Shortness of breath
  • Fatigue
  • Headache
  • Body aches

It is important to note that these symptoms can vary from person to person, and not everyone will experience all of them.

2. Severity of Illness

At this stage, there is no evidence to suggest that the Pirola variant causes more severe illness compared to other variants. However, ongoing monitoring is necessary to assess any potential changes in disease severity.

Is Vaccine Effective Against Pirola?

Understanding how current vaccines perform against the Pirola variant is essential for assessing their efficacy and informing public health strategies.

1. Efficacy of Current Vaccines Against the Pirola Variant

Studies and research are underway to evaluate the effectiveness of existing vaccines against the Pirola variant. Initial findings suggest that the current vaccines may provide some level of protection against this COVID new variant, particularly in preventing severe illness and hospitalisation.

2. Updates on Efficacy of Upcoming COVID Vaccine

The current evaluation suggests that the revised COVID-19 vaccine, anticipated for release in mid-September 2023, is expected to be effective in reducing the severity of the disease and hospitalisations.

How to Prevent Pirola Variant Infection?

Adhering to preventive measures is crucial in mitigating the spread of any COVID-19 variant, including the Pirola variant. Measures you must follow include:

  • It is crucial to continue practising preventive measures, such as wearing masks, maintaining good hand hygiene and practising social distancing. These measures help reduce the risk of transmission, regardless of the specific variant.
  • Vaccination plays a crucial role in preventing severe illness, hospitalisation and death from COVID-19. It is essential to get vaccinated as per the guidelines provided by health authorities.
  • As new coronavirus variants emerge, the need for booster doses may arise to enhance immunity against these variants.

Managing Pirola Variant Infections

To effectively manage Pirola variant infections, accurate and timely diagnosis is crucial.

1. Diagnosis and Testing for the Pirola Variant

Diagnostic methods, such as PCR tests and genomic sequencing, can detect the presence of the Pirola variant. These tests can detect the degree of infection, thus allowing doctors to take necessary measures to curb the infection.

2. Treatment Options for Pirola Variant Infections

Currently, there is limited data on specific treatments for individuals infected with the Pirola variant. However, treatment approaches used for other variants of COVID-19 can be considered while treating severe infection.

Existing medications such as nirmatrelvir-ritonavir, remdesivir and molnupiravir are likely to remain effective against this variant.

Pirola Variant and Specific Population Groups

Certain population groups may be more vulnerable to the Pirola variant, requiring additional precautions and tailored healthcare approaches.

  • The Pirola variant may pose a higher risk to vulnerable populations, such as the elderly, and immunocompromised individuals. Special attention should be given to protecting these groups through vaccination and preventive measures.
  • Parents should ensure that their children follow safety protocols in schools and other settings to prevent the spread of the virus.
  • There is currently no evidence suggesting an increased risk of severe illness from the Pirola variant specifically in pregnant women or infants. However, expectant mothers must prioritise prenatal care and follow recommended precautions to protect themselves and their babies.


Pirola is a recently discovered variant of the COVID-19 virus. The symptoms associated with Pirola infection are similar to those of other COVID variants, including fever, cough, and headache. It is essential to continue practising preventive measures such as wearing masks, maintaining social distancing, and washing hands frequently to reduce the risk of transmission. Vaccines have shown promising results in protecting against severe illness and hospitalisation caused by other variants, so it is still recommended to get vaccinated. Ongoing research and surveillance are being conducted to monitor the impact of Pirola on vaccine effectiveness and severity of illness.

Consult Apollo’s Expert Doctors


Q. Can you get Pirola variant if you've had a COVID-19 infection in the past?

It is still unclear whether previous infection provides complete protection against the Pirola variant. Hence, it is advisable to continue following preventive measures and considering vaccination, even if you have recovered from COVID-19.

Q. Are there any travel restrictions related to the Pirola variant?

Travel restrictions may vary in every region and are subject to change. It's advisable to check with relevant authorities and stay updated on travel advisories before making travel plans.

Q. What is being done to track and control the Pirola variant?

Health authorities are conducting increased surveillance and genomic sequencing to track the spread of the Pirola variant.

Q. Should I take additional precautions if the Pirola variant is in my area?

It's advisable to continue following public health guidelines, including vaccination, wearing masks and social distancing, especially if the Pirola variant is prevalent in your region.

Q. Can children be more susceptible to the Pirola variant?

Current data does not indicate that children are more susceptible to the Pirola variant than adults. However, you must follow public health guidelines in any case.


General Health

Leave Comment


Email Id


  • Share this article

  • 0

  • 0 like